{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T05:28:50Z","timestamp":1695706130469},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We report on an incidental detection of a meningioma on [<jats:sup>18<\/jats:sup>F]-2\u2032-fluoro-5-methyl-1-beta-<jats:sc>d<\/jats:sc>-arabinofuranosyluracil (<jats:sup>18<\/jats:sup>F-FMAU) PET\/CT scan that was performed during a prospective investigation of <jats:sup>18<\/jats:sup>F-FMAU PET\/CT for targeted biopsy of potential sites of tumor in men with suspected prostate cancer based on elevated prostate-specific antigen level. Neither prostate multiparamteric MRI nor <jats:sup>18<\/jats:sup>F-FMAU PET\/CT localized small volume Gleason 3 + 3 tumor deposits. However, an incidental focal high accumulation of <jats:sup>18<\/jats:sup>F-FMAU was observed in high right parietal lobe that displayed characteristics of a meningioma on a subsequent brain MRI.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002123","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T02:15:16Z","timestamp":1525918516000},"page":"e245-e246","source":"Crossref","is-referenced-by-count":3,"title":["Incidental Detection of Meningioma by 18F-FMAU PET\/CT in a Patient With Suspected Prostate Cancer"],"prefix":"10.1097","volume":"43","author":[{"given":"Bino","family":"Varghese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Velez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhushan","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Jadvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11604-016-0550-6","article-title":"Variants of meningiomas: a review of imaging findings and clinical features","volume":"34","year":"2016","journal-title":"Jpn J Radiol"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nec.2015.11.004","article-title":"Advanced imaging of intracranial meningiomas","volume":"27","year":"2016","journal-title":"Neurosurg Clin N Am"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1227\/NEU.0b013e31823bcd87","article-title":"Positron emission tomography imaging of meningioma in clinical practice: review of literature and future direction","volume":"70","year":"2012","journal-title":"Neurosurgery"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jlcr.549","article-title":"Synthesis of [18F]-labeled 2\u2032-deoxy-2\u2032-fluoro-5-methyl-1-beta-d-arabinofuranosyluracil ([18F]FMAU)","volume":"45","year":"2002","journal-title":"J Labeled Comp Radiopharm"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2967\/jnumed.107.042762","article-title":"Tumor imaging using 1-(2\u2032-deoxy-2\u2032-18F-fluoro-beta-d-arabinofuranosyl)thymine and PET","volume":"48","year":"2007","journal-title":"J Nucl Med"},{"key":"bib6-20230925","first-page":"1","article-title":"Journey of 2\u2032-deoxy-2\u2032-fluoro-methyl-1-beta-d-arabinofuranosyluracil (FMAU): from antiviral drug to PET imaging agent","volume":"25","year":"2018","journal-title":"Curr Med Chem"},{"key":"bib7-20230925","first-page":"292","article-title":"Imaging DNA synthesis in vivo with 18F-FMAU and PET","volume":"46","year":"2005","journal-title":"J Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01812286","article-title":"Thymidine kinase in extracts of human brain tumours","volume":"80","year":"1986","journal-title":"Acta Neurochir (Wien)"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201807000-00039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:05:39Z","timestamp":1695618339000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201807000-00039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002123","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}